Please login to the form below

Not currently logged in
Email:
Password:

KaloBios

This page shows the latest KaloBios news and features for those working in and with pharma, biotech and healthcare.

Post-Shkreli KaloBios pledges transparent pricing

Post-Shkreli KaloBios pledges transparent pricing

Post-Shkreli KaloBios pledges transparent pricing. Will seek input from “ key stakeholders” and share reasoning behind pricing of drugs. ... In the US benznidazole would be made available regardless of their ability to pay, while the drug will be

Latest news

More from news
Approximately 3 fully matching, plus 5 partially matching documents found.

Latest appointments

  • KaloBios names Herb Cross as CFO KaloBios names Herb Cross as CFO

    KaloBios names Herb Cross as CFO. He joins from Affymax. Herb Cross is to join KaloBios as the company's new chief financial officer. ... David Pritchard, president and CEO of KaloBios, described Cross as a “ well respected finance professional with

  • V Bryan Lawlis joins board of KaloBios V Bryan Lawlis joins board of KaloBios

    V Bryan Lawlis joins board of KaloBios. Is co-founder of Itero and Covance. ... patient-targeted, monoclonal antibodies towards commercialisation,” said David Pritchard, president and CEO of KaloBios.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics